Literature DB >> 8020006

Suramin.

M A Eisenberger1, L M Reyno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8020006     DOI： 10.1016/0305-7372(94)90003-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  10 in total

1.  Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes.

Authors:  Maryam B Lustberg; Shubham Pant; Amy S Ruppert; Tong Shen; Yong Wei; Ling Chen; Lisa Brenner; Donna Shiels; Rhonda R Jensen; Michael Berger; Ewa Mrozek; Bhuvaneswari Ramaswamy; Michael Grever; Jessie L Au; M Guillaume Wientjes; Charles L Shapiro
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-22       Impact factor: 3.333

2.  Suramin inhibits renal fibrosis in chronic kidney disease.

Authors:  Na Liu; Evelyn Tolbert; Maoyin Pang; Murugavel Ponnusamy; Haidong Yan; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 10.121

3.  Pharmacodynamics of telomerase inhibition and telomere shortening by noncytotoxic suramin.

Authors:  Yuebo Gan; Jie Lu; Bertrand Z Yeung; Christopher T Cottage; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2014-11-26       Impact factor: 4.009

4.  Suramin as a chemosensitizer: oral pharmacokinetics in rats.

Authors:  Adam Ogden; M Guillaume Wientjes; Jessie L S Au
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

5.  Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II study.

Authors:  L Miglietta; L Canobbio; C Granetto; M O Vannozzi; M Esposito; F Boccardo
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Ecto-ATPase activity on the surface of Trypanosoma cruzi and its possible role in the parasite-host cell interaction.

Authors:  Danielle F R Bisaggio; Carlos Eduardo Peres-Sampaio; José Roberto Meyer-Fernandes; Thaïs Souto-Padrón
Journal:  Parasitol Res       Date:  2003-08-22       Impact factor: 2.289

7.  Identification of phosphotyrosine mimetic inhibitors of human tyrosyl-DNA phosphodiesterase I by a novel AlphaScreen high-throughput assay.

Authors:  Christophe Marchand; Wendy A Lea; Ajit Jadhav; Thomas S Dexheimer; Christopher P Austin; James Inglese; Yves Pommier; Anton Simeonov
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

Review 8.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

9.  Suramin increased telomerase activity in the c6 glioma/wistar experimental brain tumor model.

Authors:  Mine Ergüven; Ayhan Bilir; Tuncay Altug; Fadime Aktar; Nuriye Akev
Journal:  Int J Biomed Sci       Date:  2007-06

Review 10.  Suramin's development: what did we learn?

Authors:  Maninderjeet Kaur; Eddie Reed; Oliver Sartor; William Dahut; William D Figg
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.651
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.